These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4869945)

  • 21. Glycine inhibition of asparaginase.
    Ryan WL; Sornson HC
    Science; 1970 Mar; 167(3924):1512-3. PubMed ID: 4906004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethacrynic acid--an inhibitor of L-asparagine synthetase.
    Jayaram HN; Cooney DA; Milman HA; Homan ER; King WM; Cragoe EJ
    Biochem Pharmacol; 1975 Oct; 24(19):1787-92. PubMed ID: 9943
    [No Abstract]   [Full Text] [Related]  

  • 23. [Asparaginase, leukemia and cancer].
    Levy D; Boiron M
    Bull Cancer; 1969; 56(4):365-74. PubMed ID: 4928248
    [No Abstract]   [Full Text] [Related]  

  • 24. Regeneration, tumor, dietary, and L-asparaginase effects on asparagine biosynthesis in rat liver.
    Patterson MK; Orr GR
    Cancer Res; 1969 Jun; 29(6):1179-83. PubMed ID: 4894450
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulators of the metabolism of L-asparagine: a search for endogenous inhibitors.
    Cooney DA; Jones MT; Milman HA; Young DM; Jayaram HN
    Int J Biochem; 1980; 11(6):519-39. PubMed ID: 6103827
    [No Abstract]   [Full Text] [Related]  

  • 26. [DNA-dependent RNA-polymerase activity of the lymphoid organs of mice with experimental leukemia La].
    Ioannesiants IA; Adler VV; Shapot VS
    Probl Gematol Pereliv Krovi; 1980 Feb; 25(2):26-9. PubMed ID: 7360743
    [No Abstract]   [Full Text] [Related]  

  • 27. L-Asparaginase: discovery and development as a tumor-inhibitory agent.
    Broome JD
    Cancer Treat Rep; 1981; 65 Suppl 4():111-4. PubMed ID: 7049374
    [No Abstract]   [Full Text] [Related]  

  • 28. L-asparagine and leukemia.
    Old LJ; Boyse EA; Campbell HA
    Sci Am; 1968 Aug; 219(2):34-40. PubMed ID: 4874838
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of asparaginase-induced regression of the 6C3HED lymphosarcoma by protein-free diet.
    Ryan WL; Sornson HC
    Cancer Res; 1973 May; 33(5):1062-4. PubMed ID: 4574058
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immobilized asparaginase and its use in medicine].
    Kozlov EA; Petriĭ OP
    Vopr Med Khim; 1978; 24(6):723-33. PubMed ID: 32657
    [No Abstract]   [Full Text] [Related]  

  • 31. Amino acids of the 6C3HED lymphosarcoma following treatment with asparaginase.
    Ryan WL; Dworak JE
    Cancer Res; 1970 Apr; 30(4):1206-9. PubMed ID: 4926800
    [No Abstract]   [Full Text] [Related]  

  • 32. Principal biochemical characteristics of the EC-2 L-asparaginase from Escherichia coli AT.
    Smékal F
    Neoplasma; 1969; 16(4):469-70. PubMed ID: 4899032
    [No Abstract]   [Full Text] [Related]  

  • 33. Suppression of murine leukemias by L-asparaginase. Incidence of sensitivity among leukemias of various types: comparative inhibitory activities of guinea pig serum L-asparaginase and Escherichia coli L-asparaginase.
    Boyse EA; Old LJ; Campbell HA; Mashburn LT
    J Exp Med; 1967 Jan; 125(1):17-31. PubMed ID: 5334543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaluronidase activity in murine leukaemia & lymphoma.
    Chakraborti AS; Basu A; Mitra S
    Indian J Exp Biol; 1982 May; 20(5):423-4. PubMed ID: 6957398
    [No Abstract]   [Full Text] [Related]  

  • 35. The distribution of L-asparagine synthetase in the principal organs of several mammalian and avian species.
    Milman HA; Cooney DA
    Biochem J; 1974 Jul; 142(1):27-35. PubMed ID: 4216348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzymatic and nutritional evidence for two-stage exression of the asparagine synthetase locus in L5178y murine leukemia mutants.
    Uren JR; Summers WP; Handschumacher RE
    Cancer Res; 1974 Nov; 34(11):2940-5. PubMed ID: 4529293
    [No Abstract]   [Full Text] [Related]  

  • 37. [Enzyme histochemistry in the study of the histogenesis of B- and T-cell malignant non-Hodgkin's lymphomas in primates].
    Bukaeva IA; Kove EM
    Vestn Akad Med Nauk SSSR; 1987; (10):60-5. PubMed ID: 3501208
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitors of L-asparagine synthetase, in vitro.
    Cooney DA; Driscoll JS; Milman HA; Jayaram HN; Davis RD
    Cancer Treat Rep; 1976 Oct; 60(10):1493-557. PubMed ID: 14784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytochemical markers of murine leukemias and lymphomas.
    Yoshida H; Akeho M; Okamoto K; Yumoto T
    Acta Pathol Jpn; 1981 May; 31(3):399-412. PubMed ID: 6455903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of glutamine synthetase by cortisol.
    Raina PN; Rosen F
    Biochim Biophys Acta; 1968 Oct; 165(3):470-5. PubMed ID: 4311518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.